Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · IEX Real-Time Price · USD

37.98

+0.03 (0.08%)

At close: Jul 19, 2024, 4:00 PM

37.54

-0.44 (-1.16%)

Pre-market: Jul 22, 2024, 6:58 AM EDT

Apellis Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Revenue	524.07	396.59	75.42	66.56	250.65	0	Upgrade
Revenue Growth (YoY)	394.93%	425.83%	13.31%	-73.44%	-	-	Upgrade
Cost of Revenue	70.91	58.51	5.64	0.2	0	0	Upgrade
Gross Profit	453.16	338.08	69.79	66.36	250.65	0	Upgrade
Selling, General & Admin	528.23	500.82	277.16	176.77	139.4	67.05	Upgrade
Research & Development	329.06	354.39	387.24	345.87	299.92	220.97	Upgrade
Other Operating Expenses	0	0	0	80	25.05	0	Upgrade
Operating Expenses	857.29	855.2	664.4	602.64	464.37	288.02	Upgrade
Operating Income	-404.13	-517.12	-594.61	-536.28	-213.73	-288.02	Upgrade
Interest Expense / Income	29.02	29.58	32.63	13.24	29.94	5.29	Upgrade
Other Expense / Income	-17.9	-20.21	24.26	196.48	99.37	11.41	Upgrade
Pretax Income	-415.25	-526.5	-651.5	-746	-343.03	-304.71	Upgrade
Income Tax	2.02	2.13	0.67	0.35	1.85	0	Upgrade
Net Income	-417.27	-528.63	-652.17	-746.35	-344.87	-304.71	Upgrade
Shares Outstanding (Basic)	123	119	106	84	75	62	Upgrade
Shares Outstanding (Diluted)	123	119	106	84	75	62	Upgrade
Shares Change	7.98%	11.84%	25.70%	12.32%	20.78%	14.40%	Upgrade
EPS (Basic)	-3.45	-4.45	-6.15	-8.84	-4.59	-4.90	Upgrade
EPS (Diluted)	-3.45	-4.45	-6.15	-8.84	-4.59	-4.90	Upgrade
Free Cash Flow	-550.81	-595.41	-515.27	-564.23	-165.91	-212.83	Upgrade
Free Cash Flow Per Share	-4.48	-5.02	-4.86	-6.68	-2.21	-3.42	Upgrade
Gross Margin	86.47%	85.25%	92.53%	99.70%	100.00%	-	Upgrade
Operating Margin	-77.11%	-130.39%	-788.38%	-805.67%	-85.27%	-	Upgrade
Profit Margin	-79.62%	-133.29%	-864.70%	-1121.27%	-137.59%	-	Upgrade
Free Cash Flow Margin	-105.10%	-150.13%	-683.18%	-847.66%	-66.19%	-	Upgrade
EBITDA	-384.48	-495.21	-617.39	-731.27	-312.23	-298.83	Upgrade
EBITDA Margin	-73.37%	-124.87%	-818.58%	-1098.61%	-124.57%	-	Upgrade
Depreciation & Amortization	1.75	1.7	1.49	1.49	0.86	0.6	Upgrade
EBIT	-386.23	-496.92	-618.88	-732.76	-313.09	-299.42	Upgrade
EBIT Margin	-73.70%	-125.30%	-820.55%	-1100.85%	-124.91%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).